Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 30 May, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Astec Lifesciences Ltd

About the Company - Astec Lifesciences Ltd

Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236. Currently Company is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 676.57 Cr. and Equity Capital is Rs. 19.60 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Agro Chemicals/PesticidesGodrej One, 3rd Floor, Pirojshanagar, Mumbai Maharashtra 400079astecinfo@godrejastec.com
http://www.astecls.com
Management
NamePosition Held
Mr. Nadir B GodrejChairman
Mr. Ashok V HiremathNon Executive Director
Mr. Balram Singh YadavNon Executive Director
Mr. Anurag RoyWholeTime Director & CEO
Dr. Brahma Nand VyasIndependent Director
Mr. Vijay Kashinath KhotIndependent Director
Mr. R R GovindanIndependent Director
Mr. Nandkumar DhekneIndependent Director
Ms. Anjali GupteIndependent Director
Mr. Burjis Nadir GodrejNon Executive Director

Basic Stock Data of Astec Lifesciences Ltd

Last Updated: April 8, 2024, 4:54 am

Market Cap 2,445 Cr.
Current Price 1,247
High / Low1,542/825
Stock P/E
Book Value 201
Dividend Yield0.12 %
ROCE7.82 %
ROE6.36 %
Face Value 10.0
PEG Ratio0.00

Astec Lifesciences Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales11617212910317327218420011712714311151
Expenses1001341048113020715916610512214011469
Operating Profit16382521436525331253-3-18
OPM %13%22%19%21%25%24%14%17%10%4%2%-3%-36%
Other Income3211273443211
Interest1122334566666
Depreciation77789119898999
Profit before tax11321712335815251-6-11-18-32
Tax %37%26%26%26%25%26%25%25%31%20%26%24%24%
Net Profit724139254311181-5-8-13-24
EPS in Rs3.6112.236.634.6312.6321.975.829.340.43-2.54-4.18-6.85-12.41

Last Updated: May 7, 2024, 11:23 pm

Astec Lifesciences Ltd Quarterly Chart

Astec Lifesciences Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales112174207267233299368431523555677628431
Expenses97146171213201236299354437443522551445
Operating Profit16283554326369768511215477-13
OPM %14%16%17%20%14%21%19%18%16%20%23%12%-3%
Other Income10-0-164-8121112810136
Interest679131312111213592125
Depreciation9121513101415192326343435
Profit before tax29111312295656618912135-67
Tax %29%32%22%-17%59%33%37%36%23%27%26%27%
Net Profit16915519353648659026-51
EPS in Rs0.813.304.687.602.559.8017.8718.2824.2833.2145.8513.04-25.98
Dividend Payout %62%23%21%16%0%15%8%8%6%5%3%12%

Astec Lifesciences Ltd Profit & Loss Yearly Chart

Astec Lifesciences Ltd Growth

Compounded Sales Growth
10 Years:8%
5 Years:1%
3 Years:-6%
TTM:-27%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-281%
Stock Price CAGR
10 Years:38%
5 Years:20%
3 Years:-6%
1 Year:-22%
Return on Equity
10 Years:13%
5 Years:11%
3 Years:6%
Last Year:-12%

Last Updated: April 8, 2024, 4:54 am

Astec Lifesciences Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital17181919192020202020202020
Reserves80879511699119150183227290377400375
Borrowings7473839312712712517699187279341431
Other Liabilities60838813385691198322618122121983
Total Liabilities231261284362330334413461572678897979909
Fixed Assets7612113213395103115167194213340318408
CWIP441361220842192411623127128
Investments12000000000000
Other Assets100127146216215223256275354349534534374
Total Assets231261284362330334413461572678897979909

Astec Lifesciences Ltd Reserves and Borrowings Chart

Astec Lifesciences Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 016157-13196515168-82475
Cash from Investing Activity 0-13-19-19-17-18-49-52-74-73-104-113
Cash from Financing Activity 0-231231-1-1837-95818038
Net Cash Flow01-1-021-3-0000-0

Astec Lifesciences Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days1031319114212613512210311212314890
Inventory Days237145192147177133122121131113176268
Days Payable14613211417916911615583218137179161
Cash Conversion Cycle1951451681091341528914225100145197
Working Capital Days17912212512514215411514777101163175
ROCE %5%9%11%20%12%20%22%20%20%22%22%8%

Astec Lifesciences Ltd Financial Efficiency Indicators Chart

Astec Lifesciences Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters65.23%65.20%65.20%65.19%65.29%65.29%66.77%66.76%66.76%66.76%66.75%66.75%
FIIs0.25%0.19%0.22%0.29%0.32%0.48%1.53%2.19%2.29%1.95%1.33%1.28%
DIIs10.67%10.93%12.21%12.74%12.56%11.79%9.82%9.57%10.58%10.15%10.16%9.74%
Public23.85%23.68%22.37%21.78%21.83%22.45%21.87%21.49%20.37%21.13%21.74%22.22%
No. of Shareholders19,87222,81721,07319,00216,95117,43317,63219,54517,80918,70318,72219,244

Astec Lifesciences Ltd Shareholding Pattern Chart

No. of Astec Lifesciences Ltd Shareholders

Astec Lifesciences Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Nippon India Small Cap Fund4685890.1762.02
ICICI Prudential Multicap Fund4576690.6960.58
ICICI Prudential Smallcap Fund4525460.9959.9
Nippon India Multi Cap Fund2577180.1634.11
ICICI Prudential Commodities Fund1123601.1214.87
ICICI Prudential MidCap Fund158440.052.1
ITI Value Fund119231.131.58
ITI Pharma and Healthcare Fund117541.151.56
Motilal Oswal Nifty Microcap 250 Index Fund53710.180.71

Astec Lifesciences Ltd ROCE Trend

Astec Lifesciences Ltd EPS Trend

Astec Lifesciences Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)13.0445.8733.2324.2918.28
Diluted EPS (Rs.)13.0445.8533.2124.2718.26
Cash EPS (Rs.)30.2263.3946.3236.1328.19
Book Value[Excl.RevalReserv]/Share (Rs.)214.00202.40157.91126.17103.72
Book Value[Incl.RevalReserv]/Share (Rs.)214.00202.40157.91126.17103.72
Revenue From Operations / Share (Rs.)320.40345.23283.28267.07220.38
PBDIT / Share (Rs.)45.5683.9661.0049.6344.82
PBIT / Share (Rs.)28.3966.4347.9037.7934.92
PBT / Share (Rs.)17.8261.8145.4731.3528.59
Net Profit / Share (Rs.)13.0545.8633.2224.2918.29
NP After MI And SOA / Share (Rs.)13.0445.8533.2124.2818.28
PBDIT Margin (%)14.2124.3121.5318.5820.33
PBIT Margin (%)8.8619.2416.9014.1415.84
PBT Margin (%)5.5617.9016.0511.7312.97
Net Profit Margin (%)4.0713.2811.729.098.30
NP After MI And SOA Margin (%)4.0613.2811.729.098.29
Return on Networth / Equity (%)6.0922.6621.0319.2617.64
Return on Capital Employeed (%)12.2832.0526.4029.1832.16
Return On Assets (%)2.6110.029.608.317.75
Long Term Debt / Equity (X)0.020.000.120.000.00
Total Debt / Equity (X)0.810.700.600.400.86
Asset Turnover Ratio (%)0.660.850.881.010.98
Current Ratio (X)0.941.051.031.040.99
Quick Ratio (X)0.380.670.690.660.62
Inventory Turnover Ratio (X)1.913.043.033.123.44
Dividend Payout Ratio (NP) (%)11.503.264.516.178.20
Dividend Payout Ratio (CP) (%)4.962.363.234.155.32
Earning Retention Ratio (%)88.5096.7495.4993.8391.80
Cash Earning Retention Ratio (%)95.0497.6496.7795.8594.68
Interest Coverage Ratio (X)4.3118.1725.157.717.08
Interest Coverage Ratio (Post Tax) (X)2.2410.9214.694.773.89
Enterprise Value (Cr.)3049.603711.792144.94880.191227.61
EV / Net Operating Revenue (X)4.855.493.871.682.85
EV / EBITDA (X)34.1422.5617.959.0614.01
MarketCap / Net Operating Revenue (X)4.315.083.531.502.44
Retention Ratios (%)88.4996.7395.4893.8291.79
Price / BV (X)6.468.666.343.175.20
Price / Net Operating Revenue (X)4.315.083.531.502.44
EarningsYield0.010.020.030.060.03

Astec Lifesciences Ltd Profitability Ratios (%)

Astec Lifesciences Ltd Liquidity Ratios

Astec Lifesciences Ltd Liquidity Ratios (%)

Astec Lifesciences Ltd Interest Coverage Ratios (%)

Astec Lifesciences Ltd Valuation Ratios

Strength and Weakness of Astec Lifesciences Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 15.92%, which is a positive sign.
  2. The company has higher reserves (199.85 cr) compared to borrowings (170.38 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (377.31 cr) and profit (32.85 cr) over the years.
  1. The stock has a high average Working Capital Days of 135.42, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 133.42, which may not be favorable.

FAQ

What is the latest fair value of Astec Lifesciences Ltd?

The latest fair value of Astec Lifesciences Ltd is 0.00.

What is the Market Cap of Astec Lifesciences Ltd?

The Market Cap of Astec Lifesciences Ltd is 2,445 Cr..

What is the current Stock Price of Astec Lifesciences Ltd as on 13 April 2024?

The current stock price of Astec Lifesciences Ltd as on 13 April 2024 is 1,247.

What is the High / Low of Astec Lifesciences Ltd stocks in FY 2024?

In FY 2024, the High / Low of Astec Lifesciences Ltd stocks is ₹1,542/825.

What is the Stock P/E of Astec Lifesciences Ltd?

The Stock P/E of Astec Lifesciences Ltd is .

What is the Book Value of Astec Lifesciences Ltd?

The Book Value of Astec Lifesciences Ltd is 201.

What is the Dividend Yield of Astec Lifesciences Ltd?

The Dividend Yield of Astec Lifesciences Ltd is 0.12 %.

What is the ROCE of Astec Lifesciences Ltd?

The ROCE of Astec Lifesciences Ltd is 7.82 %.

What is the ROE of Astec Lifesciences Ltd?

The ROE of Astec Lifesciences Ltd is 6.36 %.

What is the Face Value of Astec Lifesciences Ltd?

The Face Value of Astec Lifesciences Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Astec Lifesciences Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE